These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Fong CT; White PS; Peterson K; Sapienza C; Cavenee WK; Kern SE; Vogelstein B; Cantor AB; Look AT; Brodeur GM Cancer Res; 1992 Apr; 52(7):1780-5. PubMed ID: 1551108 [TBL] [Abstract][Full Text] [Related]
5. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. Caron H; van Sluis P; de Kraker J; Bökkerink J; Egeler M; Laureys G; Slater R; Westerveld A; Voûte PA; Versteeg R N Engl J Med; 1996 Jan; 334(4):225-30. PubMed ID: 8531999 [TBL] [Abstract][Full Text] [Related]
6. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. Bown N; Cotterill S; Lastowska M; O'Neill S; Pearson AD; Plantaz D; Meddeb M; Danglot G; Brinkschmidt C; Christiansen H; Laureys G; Speleman F; Nicholson J; Bernheim A; Betts DR; Vandesompele J; Van Roy N N Engl J Med; 1999 Jun; 340(25):1954-61. PubMed ID: 10379019 [TBL] [Abstract][Full Text] [Related]
7. The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children. Fröstad B; Martinsson T; Tani E; Falkmer U; Darnfors C; Skoog L; Kogner P Cancer; 1999 Apr; 87(2):60-8. PubMed ID: 10227595 [TBL] [Abstract][Full Text] [Related]
8. Neuroblastic and Schwannian stromal cells of neuroblastoma are derived from a tumoral progenitor cell. Mora J; Cheung NK; Juan G; Illei P; Cheung I; Akram M; Chi S; Ladanyi M; Cordon-Cardo C; Gerald WL Cancer Res; 2001 Sep; 61(18):6892-8. PubMed ID: 11559566 [TBL] [Abstract][Full Text] [Related]
9. Proof of the reactive nature of the Schwann cell in neuroblastoma and its clinical implications. Ambros IM; Zellner A; Stock C; Amann G; Gadner H; Ambros PF Prog Clin Biol Res; 1994; 385():331-7. PubMed ID: 7972228 [No Abstract] [Full Text] [Related]
10. Neuroblastoma: clinical significance of genetic abnormalities. Brodeur GM Cancer Surv; 1990; 9(4):673-88. PubMed ID: 2101728 [TBL] [Abstract][Full Text] [Related]
11. Analysis of genomic imprinting at 1p35-36 in neuroblastoma. Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906 [TBL] [Abstract][Full Text] [Related]
12. Deletion mapping of chromosomes 14q and 1p in human neuroblastoma. Takayama H; Suzuki T; Mugishima H; Fujisawa T; Ookuni M; Schwab M; Gehring M; Nakamura Y; Sugimura T; Terada M Oncogene; 1992 Jun; 7(6):1185-9. PubMed ID: 1594247 [TBL] [Abstract][Full Text] [Related]
13. The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma. Gehring M; Berthold F; Edler L; Schwab M; Amler LC Cancer Res; 1995 Nov; 55(22):5366-9. PubMed ID: 7585602 [TBL] [Abstract][Full Text] [Related]
14. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group. Lastowska M; Nacheva E; McGuckin A; Curtis A; Grace C; Pearson A; Bown N Genes Chromosomes Cancer; 1997 Mar; 18(3):162-9. PubMed ID: 9071568 [TBL] [Abstract][Full Text] [Related]
15. A neuroblastoma cell line derived from a case detected through a mass screening system in Japan: a case report including the biologic and phenotypic characteristics of the cell line. Hiraiwa H; Hamazaki M; Takata A; Kikuchi H; Hata J Cancer; 1997 May; 79(10):2036-44. PubMed ID: 9149033 [TBL] [Abstract][Full Text] [Related]
16. Detection of MYCN gene amplification and deletions of chromosome 1p in neuroblastoma by in situ hybridization using routine histologic sections. Leong PK; Thorner P; Yeger H; Ng K; Zhang Z; Squire J Lab Invest; 1993 Jul; 69(1):43-50. PubMed ID: 8331897 [TBL] [Abstract][Full Text] [Related]
17. Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore. Yong MH; Hwang WS; Knight LA; Fung W; Chan MY; Seow WT; Chui CH Singapore Med J; 2009 Nov; 50(11):1090-4. PubMed ID: 19960166 [TBL] [Abstract][Full Text] [Related]
19. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963 [TBL] [Abstract][Full Text] [Related]
20. Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas. Ambros PF; Ambros IM; Kerbl R; Luegmayr A; Rumpler S; Ladenstein R; Amann G; Kovar H; Horcher E; De Bernardi B; Michon J; Gadner H Med Pediatr Oncol; 2001 Jan; 36(1):1-4. PubMed ID: 11464855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]